Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

The Zepbound LillyDirect offers comes in a single-dose vial rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available are 2.5 milligrams (mg) and 5 mg, which is ...

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

But the LillyDirect Zepbound offer is for vials that patients ... the vials compared to a list price of $1,086.37 per monthly injector pen. Wegovy's maker, Novo Nordisk, is charging $499 per ...

Weight loss medications like Wegovy and Zepbound can be effective but may pose risks for older adults, including muscle loss and bone density decline.

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly ... vials compared to a list price of $1,086.37 per monthly injector pen. Customers can't get their health insurance ...